Answers are grounded in this paper and cite their sources.
Treatment reduces therapy-induced hyperglycemia in pediatric patients, suggesting metformin use may limit insulin reliance.
Oral metformin proved to be a safe and effective first-line option for managing TIH in pediatric ALL. Insulin therapy could be avoided in majority of the patients (73.4% in induction, 68.1% in re-induction), making this drug an attractive first-line option for children with treatment-induced non-severe hyperglycemia.
No takes yet. Share an insight, caveat, or question.
Chakraborty et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: